Suppr超能文献

撒哈拉以南非洲普通人群中丙型肝炎病毒的危险因素——系统评价数据分析

Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa-An Analysis of Systematic Review Data.

作者信息

Kassa Getahun Molla, Lim Aaron G, Tamiru Melaku Tileku, Alamneh Tesfa Sewunet, Vickerman Peter, Dagne Emebet, Mulu Andargachew, Baissa Obsie, Paltiel Ora, Dillon John F, Yesuf Elias Ali, Hickman Matthew, Walker Josephine G, French Clare E

机构信息

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

出版信息

J Viral Hepat. 2025 Oct;32(10):e70065. doi: 10.1111/jvh.70065.

Abstract

Understanding risk factors for hepatitis C virus (HCV) is critical for targeting screening and prevention. We systematically reviewed risk factors associated with HCV seroprevalence among the general population in sub-Saharan Africa (SSA). Comprehensive systematic review of HCV seroprevalence of community-based observational studies reporting HCV risk factors in SSA. Study quality was assessed using Joanna Briggs Institute tool. Random effect meta-analyses were used to estimate odds ratios (OR) with 95% confidence intervals (CI). We identified 92 studies. Higher odds of HCV seroprevalence were observed among age 21-64 (OR = 1.77, 95% CI 1.17-2.68) and 65+ groups (OR = 11.75, 95% CI 5.51-25.05) compared to those aged ≤ 20 years; not being formally educated (OR = 1.78, 95% CI 1.35-2.35) compared to secondary/above and being married (OR = 1.91, 95% CI 1.45-2.51) or divorced (OR = 3.20, 95% CI 1.91-5.36) compared to never married. Family history of HCV (OR = 1.52, 95% CI 1.17-1.96), being a person living with HIV (OR = 2.64, 95% CI 1.61-4.33) or being HBsAg positive (OR = 1.66, 95% CI 1.10-2.50) were all positively associated with increased HCV seroprevalence, as was having a history of blood transfusion (OR = 1.81, 95% CI 1.33-2.45), hospitalisation (OR = 1.55, 95% CI 1.22-1.96), medical operation (OR = 1.28, 95% CI 1.01-1.62), scarification (OR = 1.29, 95% CI 1.01-1.64) and injection drug use (OR = 7.04, 95% CI 1.16-42.68). Pilot HCV screening programmes targeting older adults and people exposed to healthcare-associated factors could potentially lead to the efficient detection of HCV cases and reduce future HCV exposures among the general population in SSA countries.

摘要

了解丙型肝炎病毒(HCV)的风险因素对于确定筛查和预防目标至关重要。我们系统回顾了撒哈拉以南非洲(SSA)普通人群中与HCV血清流行率相关的风险因素。对SSA中报告HCV风险因素的基于社区的观察性研究的HCV血清流行率进行全面系统回顾。使用乔安娜·布里格斯研究所工具评估研究质量。采用随机效应荟萃分析来估计比值比(OR)及95%置信区间(CI)。我们纳入了92项研究。与年龄≤20岁的人群相比,21 - 64岁组(OR = 1.77,95% CI 1.17 - 2.68)和65岁及以上组(OR = 11.75,95% CI 5.51 - 25.05)的HCV血清流行率较高;与接受过中等及以上教育的人群相比,未接受过正规教育的人群(OR = 1.78,95% CI 1.35 - 2.35),与从未结婚的人群相比,已婚人群(OR = 1.91,95% CI 1.45 - 2.51)或离婚人群(OR = 3.20,95% CI 1.91 - 5.36)的HCV血清流行率较高。HCV家族史(OR = 1.52,95% CI 1.17 - 1.96)、感染艾滋病毒者(OR = 2.64,95% CI 1.61 - 4.33)或乙肝表面抗原阳性者(OR = 1.66,95% CI 1.10 - 2.50)均与HCV血清流行率增加呈正相关,有输血史(OR = 1.81,95% CI 1.33 - 2.45)、住院史(OR = 1.55,95% CI 1.22 - 1.96)、手术史(OR = 1.28,95% CI 1.01 - 1.62)、划痕纹身史(OR = 1.29,95% CI 1.01 - 1.64)和注射吸毒史(OR = 7.04,95% CI 1.16 - 42.68)也呈正相关。针对老年人和接触医疗相关因素人群的HCV筛查试点项目可能会有效检测出HCV病例,并减少SSA国家普通人群未来的HCV暴露。

相似文献

2
Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis.
Lancet Infect Dis. 2015 Jul;15(7):819-24. doi: 10.1016/S1473-3099(15)00006-7. Epub 2015 May 5.
3
Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis.
Lancet Glob Health. 2017 Oct;5(10):e992-e1003. doi: 10.1016/S2214-109X(17)30298-X.
6
Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis.
J Viral Hepat. 2016 Apr;23(4):244-55. doi: 10.1111/jvh.12481. Epub 2015 Oct 19.
8
Epidemiology of hepatitis B, C and D in Malawi: systematic review.
BMC Infect Dis. 2018 Oct 12;18(1):516. doi: 10.1186/s12879-018-3428-7.

本文引用的文献

3
Burden of liver cancer due to hepatitis C from 1990 to 2019 at the global, regional, and national levels.
Front Oncol. 2023 Dec 19;13:1218901. doi: 10.3389/fonc.2023.1218901. eCollection 2023.
4
Strategies for Removal of Barriers to Hepatitis C Elimination in Sub-Saharan Africa.
J Infect Dis. 2023 Sep 13;228(Suppl 3):S221-S225. doi: 10.1093/infdis/jiad088.
5
Population-Based Testing for Undiagnosed Hepatitis C: A Systematic Review of Economic Evaluations.
Appl Health Econ Health Policy. 2022 Mar;20(2):171-183. doi: 10.1007/s40258-021-00694-w. Epub 2021 Dec 6.
7
8
Overview of the epidemiological conditions of HIV among key populations in Africa.
J Int AIDS Soc. 2021 Jul;24 Suppl 3(Suppl 3):e25716. doi: 10.1002/jia2.25716.
10
Is the universal population Hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence.
Rev Esp Quimioter. 2020 Aug;33(4):240-248. doi: 10.37201/req/030.2020. Epub 2020 Jun 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验